The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK

Author: Benedict Ágnes  

Publisher: Adis International

ISSN: 1170-7690

Source: PharmacoEconomics, Vol.28, Iss.3, 2010-03, pp. : 185-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract